The innovative technology behind xken health – clinical proteome analysis – makes the test unique.
The clinical proteome analysis of xken health developed in 20 years of clinical research
The basis of the xken healthDiagnostics is based on two decades of intensive research with international scientists. During this time, the technology was developed, the database was built, and disease-specific protein patterns were defined. Clinical proteome analysis is performed using a combination of capillary electrophoresis and mass spectrometry (CE-MS). This method is consistently used in clinical trials. We will continue to generate disease-specific protein patterns in the future.
>85.000
Samples and data sets
>400
scientific publications
>100
clinical trials
The CE-MS technology developed and patented by Prof. Dr. Harald Mischak enables early and precise diagnosis of diseases. By comparing the proteome with previously defined disease-specific protein patterns in the database, the individual's health status can be mapped.
The advantage for you lies in the detection of the disease at a time when appropriate therapy can still halt the damage to the organs. The medicine of the future will be increasingly individualized, driven more by the idea of optimizing one's own body than by repairing temporary deficiencies.
Research into disease markers usually begins with an initial request from scientists at university hospitals. With each clinical study, new insights from proteomic analysis are gained to establish and validate new disease profiles. All data from these studies are fed into our database. Further studies are planned for your benefit in the future.
Our strength lies in our ability to compare every sample with the numerous data sets in our database. Every disease has its own disease-specific protein pattern. Each sample contains thousands of proteins and their fragments (peptides). We analyze these qualitatively and quantitatively with your sample. The high precision of xken is not based on a single marker, but on a combination of hundreds of disease markers.
Some of the prominent scientists involved in the clinical studies underlying xken health:
Prof. Dr.
Antonia Vlahou
... and many more!
